SANUWAVE Health Inc. (SNWV), a provider of next-generation FDA-approved wound care products, is slated to release its full Q1 results on or around May 9, 2025.
The company's lead product, the UltraMIST Therapy System, has received FDA approval for a range of wound types, including diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. In 2024, SANUWAVE sold 374 UltraMIST systems compared to 211 in the prior year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.